ODP158 A Pilot Trial on the Efficacy of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness

OBJECTIVE: Maternally inherited diabetes and deafness (MIDD) is characterized by progressive insulin secretory disorder caused by impairment of mitochondrial adenosine triphosphate (ATP) production in pancreatic beta-cells. The amino acid 5-aminolevulinic acid (5-ALA) is the first heme biosynthetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Yuta, Haraguchi, Ai, Shigeno, Riyoko, Horie, Ichiro, Abiru, Norio, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624740/
http://dx.doi.org/10.1210/jendso/bvac150.613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624740/
http://dx.doi.org/10.1210/jendso/bvac150.613

Ejemplares similares